EA201891470A1 - Способ кристаллизации для получения кристаллов гемигидрата канаглифлозина - Google Patents
Способ кристаллизации для получения кристаллов гемигидрата канаглифлозинаInfo
- Publication number
- EA201891470A1 EA201891470A1 EA201891470A EA201891470A EA201891470A1 EA 201891470 A1 EA201891470 A1 EA 201891470A1 EA 201891470 A EA201891470 A EA 201891470A EA 201891470 A EA201891470 A EA 201891470A EA 201891470 A1 EA201891470 A1 EA 201891470A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- obtaining
- crystallization method
- canagliflosine
- hemihydrate crystals
- vessel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
Настоящее изобретение относится к улучшенному способу кристаллизации для получения кристаллов гемигидрата канаглифлозина, характеризующихся узким распределением частиц по размеру, путем удаления небольшой части кристаллической суспензии в кристаллизационном сосуде из указанного сосуда и проведения в указанной части уменьшения размера частиц образующихся кристаллов с последующим нагреванием и повторным внесением указанной части кристаллической суспензии вновь в кристаллизационный сосуд, который выдерживают в определенном диапазоне температур.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15201459 | 2015-12-21 | ||
| EP16172070 | 2016-05-31 | ||
| PCT/EP2016/081861 WO2017108752A1 (en) | 2015-12-21 | 2016-12-20 | Crystallization procedure for obtaining canagliflozin hemihydrate crystals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201891470A1 true EA201891470A1 (ru) | 2018-12-28 |
| EA036793B1 EA036793B1 (ru) | 2020-12-22 |
Family
ID=57681580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201891470A EA036793B1 (ru) | 2015-12-21 | 2016-12-20 | Способ кристаллизации для получения кристаллов гемигидрата канаглифлозина |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10323025B2 (ru) |
| EP (1) | EP3394051B1 (ru) |
| JP (1) | JP6851379B2 (ru) |
| KR (1) | KR20180095839A (ru) |
| CN (1) | CN108368096B (ru) |
| AU (1) | AU2016376653B2 (ru) |
| CA (1) | CA3006237C (ru) |
| CY (1) | CY1124885T1 (ru) |
| DK (1) | DK3394051T3 (ru) |
| EA (1) | EA036793B1 (ru) |
| ES (1) | ES2794909T3 (ru) |
| HR (1) | HRP20200755T1 (ru) |
| HU (1) | HUE049895T2 (ru) |
| LT (1) | LT3394051T (ru) |
| PL (1) | PL3394051T3 (ru) |
| PT (1) | PT3394051T (ru) |
| SI (1) | SI3394051T1 (ru) |
| WO (1) | WO2017108752A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3148236A1 (en) | 2019-07-22 | 2021-01-28 | Canopy Growth Corporation | Continuous crystallization of cannabinoids in a stirred-tank reactor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2780403B3 (fr) * | 1998-06-24 | 2000-07-21 | Sanofi Sa | Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant |
| GB0301259D0 (en) * | 2003-01-20 | 2003-02-19 | Novartis Ag | Organic compounds |
| CN104109155A (zh) | 2003-08-01 | 2014-10-22 | 田边三菱制药株式会社 | 新颖化合物 |
| EP2054878B1 (en) * | 2006-08-15 | 2012-03-28 | Broadcom Corporation | Constrained and controlled decoding after packet loss |
| UY30730A1 (es) * | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
| US8772512B2 (en) * | 2009-07-10 | 2014-07-08 | Janssen Pharmaceutica Nv | Crystallisation process for 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene |
| WO2014180872A1 (en) | 2013-05-08 | 2014-11-13 | Lek Pharmaceuticals D.D. | NOVEL CRYSTALLINE HYDRATES OF 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE |
| CZ2014207A3 (cs) * | 2014-03-28 | 2015-05-27 | Bochemie A.S. | Diskontinuální krystalizační jednotka pro výrobu kulovitých krystalů |
| CN103896930B (zh) * | 2014-04-02 | 2016-08-17 | 安徽联创生物医药股份有限公司 | 卡格列净半水合物药用晶型的制备方法 |
-
2016
- 2016-12-20 CA CA3006237A patent/CA3006237C/en active Active
- 2016-12-20 LT LTEP16819899.2T patent/LT3394051T/lt unknown
- 2016-12-20 SI SI201630770T patent/SI3394051T1/sl unknown
- 2016-12-20 JP JP2018532225A patent/JP6851379B2/ja active Active
- 2016-12-20 AU AU2016376653A patent/AU2016376653B2/en active Active
- 2016-12-20 EA EA201891470A patent/EA036793B1/ru unknown
- 2016-12-20 ES ES16819899T patent/ES2794909T3/es active Active
- 2016-12-20 US US16/064,084 patent/US10323025B2/en active Active
- 2016-12-20 PL PL16819899T patent/PL3394051T3/pl unknown
- 2016-12-20 CN CN201680074830.6A patent/CN108368096B/zh active Active
- 2016-12-20 KR KR1020187018513A patent/KR20180095839A/ko active Search and Examination
- 2016-12-20 HU HUE16819899A patent/HUE049895T2/hu unknown
- 2016-12-20 DK DK16819899.2T patent/DK3394051T3/da active
- 2016-12-20 EP EP16819899.2A patent/EP3394051B1/en active Active
- 2016-12-20 WO PCT/EP2016/081861 patent/WO2017108752A1/en active Application Filing
- 2016-12-20 PT PT168198992T patent/PT3394051T/pt unknown
-
2020
- 2020-05-11 HR HRP20200755TT patent/HRP20200755T1/hr unknown
- 2020-07-09 CY CY20201100631T patent/CY1124885T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20180095839A (ko) | 2018-08-28 |
| JP2019504022A (ja) | 2019-02-14 |
| PL3394051T3 (pl) | 2020-10-19 |
| LT3394051T (lt) | 2020-08-10 |
| AU2016376653B2 (en) | 2020-07-30 |
| ES2794909T3 (es) | 2020-11-19 |
| SI3394051T1 (sl) | 2020-07-31 |
| WO2017108752A1 (en) | 2017-06-29 |
| US10323025B2 (en) | 2019-06-18 |
| DK3394051T3 (da) | 2020-07-20 |
| HUE049895T2 (hu) | 2020-11-30 |
| EP3394051A1 (en) | 2018-10-31 |
| PT3394051T (pt) | 2020-06-08 |
| CY1124885T1 (el) | 2022-07-22 |
| JP6851379B2 (ja) | 2021-03-31 |
| EP3394051B1 (en) | 2020-04-22 |
| HRP20200755T1 (hr) | 2020-07-24 |
| AU2016376653A1 (en) | 2018-06-07 |
| US20190002449A1 (en) | 2019-01-03 |
| CN108368096B (zh) | 2021-12-10 |
| CA3006237C (en) | 2023-10-03 |
| CA3006237A1 (en) | 2017-06-29 |
| CN108368096A (zh) | 2018-08-03 |
| EA036793B1 (ru) | 2020-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201706214B (en) | Process for producing stabilized polyacrylamide compositions | |
| TW201613866A (en) | Process for preparing fluorinated iminopyridine compounds | |
| MX2017004739A (es) | Proceso estereoselectivo para obtener metilamidas del acido (z)-5-cicliloxi-2[(e)-metoximino]-3-metil-pent-3-enico usando mezcla de isomeros e, z e intermediarios de aquellas. | |
| EP3142815A4 (en) | New powder metal process for production of components for high temperature useage | |
| PH12016501941A1 (en) | Use of heterocyclic compounds for controlling nematodes | |
| MX2018004923A (es) | Aceite de sabadilla. | |
| GEP20197040B (en) | Solid forms of menaquinols | |
| WO2016024286A3 (en) | An improved process for synthesis of lenalidomide | |
| IN2014MU00675A (ru) | ||
| MA39480A (fr) | Nouveau procédé pour la préparation de prostaglandines de haute pureté | |
| MX2016012125A (es) | Procedimiento y dispositivo para separar una sustancia de una solucion. | |
| MY173792A (en) | Process for obtaining methionine | |
| EA201891470A1 (ru) | Способ кристаллизации для получения кристаллов гемигидрата канаглифлозина | |
| MX2019002017A (es) | Derivados de sofosbuvir para el tratamiento de la hepatitis c. | |
| HUE061878T2 (hu) | A kristályos rozuvasztatin kalcium új polimorf formája és új eljárások a kristályos és amorf rozuvasztatin kalcium elõállítására | |
| ZA201808254B (en) | Method for producing crystal of uracil compound | |
| GB201814291D0 (en) | Process for the production of gallium radionculides | |
| IL262524B (en) | Ticn with reduced growth defects through the use of hipims | |
| EP3260535A4 (en) | Method for mass production of mouse ovum based on novel superovulation-induction treatment | |
| PT3397609T (pt) | Processo de produção de cetonas a partir de álcoois secundários | |
| DK3177636T3 (da) | Fremgangsmåde til fremstilling af blandinger af proteinfaktorer fra bovint colostrum med høj renhed | |
| IN2013MU02843A (ru) | ||
| IN2015CH02092A (ru) | ||
| SG11201700697YA (en) | Crystal of alkali metal n-acetylneuraminate anhydrate, and process for producing same | |
| IN2015CH00214A (ru) |